Frontiers in Immunology, 2024
Exploring causal correlations between inflammatory cytokines and Ménière’s disease: a Mendelian randomization

Xie S., Zhang R., Tang Y. et al.

Communications Biology, 2024
GWAS meta-analysis reveals key risk loci in essential tremor pathogenesis

Skuladottir A., Stefansdottir L., Halldorsson G. et al.

Obesity, 2024
Obesity‐related inflammatory protein signature in cardiovascular clinical outcomes: results from the Gutenberg Health Study

Panova‐Noeva M., Koeck T., Schoelch C. et al.

Cell Reports Medicine, 2024
Multi-omic profiling reveals the endogenous and neoplastic responses to immunotherapies in cutaneous T cell lymphoma

Glass D., Mayer-Blackwell K., Ramchurren N. et al.

Clinical Proteomics, 2024
Multiplex proteomics identifies inflammation-related plasma biomarkers for aging and cardio-metabolic disorders

Wu S., Li Y., Zhao X. et al.

Genome Medicine, 2024
Metabolic and inflammatory perturbation of diabetes associated gut dysbiosis in people living with and without HIV infection

Luo K., Peters B., Moon J. et al.

Scientific Reports, 2024
TMAO enhances TNF-α mediated fibrosis and release of inflammatory mediators from renal fibroblasts

Stefania K., Ashok K., Geena P. et al.

Frontiers in Immunology, 2024
Patient-derived tumoroids and proteomic signatures: tools for early drug discovery

Lê H., Deforges J., Cutolo P. et al.

Frontiers in Genetics, 2024
Circulating VEGF and inflammatory bowel disease: a bidirectional mendelian randomization

Lin H., Cao B.

Alzheimer's & Dementia, 2024
MINocyclinE to Reduce inflammation and blood‐brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double‐blind, placebo‐controlled experimental medicine trial

Brown R., Tozer D., Loubière L. et al.

Molecular Medicine, 2024
The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis

Patel M., Fraser D., Daley M. et al.

Nature Genetics, 2024
Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis

Ghouse J., Sveinbjörnsson G., Vujkovic M. et al.

The Journal of Clinical Endocrinology & Metabolism, 2024
Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes

Gurung R., Zheng H., Koh H. et al.

Diabetes Care, 2024
Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes

Yao P., Iona A., Pozarickij A. et al.

Clinica Chimica Acta, 2024
Targeted plasma proteomic analysis uncovers a high-performance biomarker panel for early diagnosis of gastric cancer

Feng T., Jie M., Deng K. et al.

Journal for ImmunoTherapy of Cancer, 2024
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma

Coffey D., Osman K., Aleman A. et al.

JID Innovations, 2024
Dupilumab Therapy Modulates Circulating Inflammatory Mediators in Patients with Prurigo Nodularis

Bao A., Ma E., Cornman H. et al.

International Journal of Molecular Sciences, 2024
Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis

Miyano T., Mikkaichi T., Nakamura K. et al.

Angiogenesis, 2024
Interleukin-6 drives endothelial glycocalyx damage in COVID-19 and bacterial sepsis

Drost C., Rovas A., Osiaevi I. et al.

Muscle & Nerve, 2024
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes

Lindborg S., Goyal N., Katz J. et al.